An injective treatment of postobese cutaneous and subcutaneous tissue consisting of HCC may have a role in counteracting these histopathological alterations, by yielding increased production and deposition of collagen and elastin fibers in the dermal and subdermal layers. This evidence concerns the gene ELN and hepatocellular carcinoma.